Clinical development of fixed combination medicinal products

Keywords Fixed combination medicinal products, guidance, clinical development
Description Revision 2 replaces 'Guideline on clinical development of fixed combination medicinal products' (CHMP/EWP/240/95 Rev. 1). This guideline covers fixed combination medicinal products containing two or more active substances within a single pharmaceutical form. The active substances may be authorised substances or substances that have not yet been authorised in the EU.

Document history

How useful was this page?

Add your rating
Average
1 rating